100 King St W, Suite 3400, 1 First Canadian Pl, PO Box 130, Toronto, ON
Year called to bar: 1999 (ON); 2003 (New York)
Dominique is Vice Chair & Toronto Managing Partner at Bennett Jones. She leads the firm's Intellectual Property Litigation group and is co-head of its Innovation, Technology and Branding group. She was named Outstanding Practitioner in Patent Law by Managing IP in their Americas Awards in 2020 and was a finalist for the 2021 Canadian Patent Litigator of the Year (LMG Life Sciences Awards North America). For the last five years, Managing Intellectual Property has named her in the Top 250 Women in IP in the world. Dominique's practice involves all aspects of IP litigation and dispute resolution with particular emphasis on litigation involving pharma/biotech and energy-related patents, and trademarks. She counsels on trademark, patent, copyright, trade secret, advertising, marketing, packaging, labelling, and regulatory matters—most often pertaining to pharmaceuticals, biologics, legal cannabis, food and beverages, medical devices, and natural health products. Dominique regularly consults on transactions involving IP and regulated industries. She is depended on to structure and negotiate complex strategic settlements and arrangements, with an eye to positive business and litigation outcomes.
Concordia International Corp. (“Concordia” or the “Company”) (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in European specialty, off-patent medicines, completed the recapitalization of approximately US$4 billion of secured and unsecured debt in September 2018 pursuant to a plan of arrangement (the “CBCA Plan”) under the Canada Business Corporations Act (“CBCA”).